Needham analyst Serge Belanger maintained a Hold rating on Verrica Pharmaceuticals today. The company’s shares closed last Wednesday at $5.91. According to TipRanks.com, Belanger is a 5-star analyst ...

Times reporters and editors are digging through millions of pages of Jeffrey Epstein documents released by the Justice Department, and tracking the fallout. Times reporters and editors are digging ...

An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models. The consensus rating for Verrica Pharmaceuticals is ...

When computer systems are used for extended periods, memory space becomes clogged, and Windows performance becomes sluggish. If you notice your hard disk space is slowly filling up, freeing up some ...

“A nation that is afraid to let its people judge the truth and falsehood in an open market is a nation that is afraid of its people.” – John F. Kennedy On November 22, 1963, crowds of excited people ...

Tune into live earnings calls Now streaming directly on quote pages.

Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...

Enhance your stock picks with dividend metrics like per-share dividends, yield, frequency, payout ratios, and more.

Verrica Pharmaceuticals, Inc. is a dermatology therapeutics company, which engages in identifying, developing, and commercializing pharmaceutical products for the treatment of skin diseases. Its ...